Correlation Between Veritas Pharma and Sangui Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veritas Pharma and Sangui Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veritas Pharma and Sangui Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veritas Pharma and Sangui Biotech International, you can compare the effects of market volatilities on Veritas Pharma and Sangui Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veritas Pharma with a short position of Sangui Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veritas Pharma and Sangui Biotech.

Diversification Opportunities for Veritas Pharma and Sangui Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Veritas and Sangui is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Veritas Pharma and Sangui Biotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangui Biotech Inter and Veritas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veritas Pharma are associated (or correlated) with Sangui Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangui Biotech Inter has no effect on the direction of Veritas Pharma i.e., Veritas Pharma and Sangui Biotech go up and down completely randomly.

Pair Corralation between Veritas Pharma and Sangui Biotech

If you would invest  0.02  in Sangui Biotech International on December 29, 2024 and sell it today you would earn a total of  0.00  from holding Sangui Biotech International or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.31%
ValuesDaily Returns

Veritas Pharma  vs.  Sangui Biotech International

 Performance 
       Timeline  
Veritas Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Veritas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Veritas Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Sangui Biotech Inter 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Sangui Biotech is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Veritas Pharma and Sangui Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veritas Pharma and Sangui Biotech

The main advantage of trading using opposite Veritas Pharma and Sangui Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veritas Pharma position performs unexpectedly, Sangui Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangui Biotech will offset losses from the drop in Sangui Biotech's long position.
The idea behind Veritas Pharma and Sangui Biotech International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance